L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas

Citation:

Florou D, Papadopoulos IN, Fragoulis EG, Scorilas A. L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas. Journal of cancer research and clinical oncology. 2013;139:297–306.

Contact Details

National and Kapodistrian University of Athens, University General Hospital 'Attikon', Fourth Surgery Department,
Mobile +30 6944 661 484

Athens, ZipCode 12462
ipapado@med.uoa.gr
ina.papadopoulos@gmail.com

<embed>

Recent Publications

Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients
Femoral fractures are an indicator of increased severity of injury for road traffic collision victims: an autopsy–based case–control study on 4895 fatalities
Histopathologic study of Mucinous lesions of the appendix

Submitted (1)
2021 (1)
2020 (5)
2019 (1)
2018 (5)
2017 (17)
2016 (4)
2015 (3)
2014 (20)
2013 (12)

Iordanis Papadopoulos

Professor, Medicine

L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas

Citation:

Contact Details

Recent Publications

Publications per year